Ben-Shimol S, Givon-Lavi N, Greenberg D, Stein M, Megged O, Bar-Yochai A
Euro Surveill. 2018; 23(47).
PMID: 30482264
PMC: 6341944.
DOI: 10.2807/1560-7917.ES.2018.23.47.1800081.
Tremblay C, Bourgault A, St-Antoine P
Can J Infect Dis. 2012; 7(3):205-7.
PMID: 22514439
PMC: 3327403.
DOI: 10.1155/1996/232985.
Agrawal S, Nadel S
Paediatr Drugs. 2011; 13(6):385-400.
PMID: 21999651
DOI: 10.2165/11593340-000000000-00000.
Langley J
Paediatr Child Health. 2010; 6(6):322-4.
PMID: 20084256
PMC: 2804755.
DOI: 10.1093/pch/6.6.322.
Paediatr Child Health. 2010; 6(3):147-60.
PMID: 20084227
PMC: 2804530.
DOI: 10.1093/pch/6.3.147.
Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone.
Egermann U, Stanga Z, Ramin A, Acosta F, Stucki A, Gerber P
Antimicrob Agents Chemother. 2009; 53(7):3030-3.
PMID: 19364870
PMC: 2704679.
DOI: 10.1128/AAC.00952-08.
Efficacy of telavancin against penicillin-resistant pneumococci and Staphylococcus aureus in a rabbit meningitis model and determination of kinetic parameters.
Stucki A, Gerber P, Acosta F, Cottagnoud M, Cottagnoud P
Antimicrob Agents Chemother. 2006; 50(2):770-3.
PMID: 16436742
PMC: 1366883.
DOI: 10.1128/AAC.50.2.770-773.2006.
Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolated in Algiers, Algeria.
Ramdani-Bouguessa N, Rahal K
Antimicrob Agents Chemother. 2003; 47(2):824-6.
PMID: 12543703
PMC: 151779.
DOI: 10.1128/AAC.47.2.824-826.2003.
Dissemination of Streptococcus pneumoniae clone Colombia(5)-19 in Latin America.
Gamboa L, Camou T, Hortal M, Castaneda E
J Clin Microbiol. 2002; 40(11):3942-50.
PMID: 12409356
PMC: 139718.
DOI: 10.1128/JCM.40.11.3942-3950.2002.
The emergence of resistant pneumococcal meningitis--implications for empiric therapy.
McMaster P, McIntyre P, Gilmour R, Gilbert L, Kakakios A, Mellis C
Arch Dis Child. 2002; 87(3):207-10.
PMID: 12193427
PMC: 1719212.
DOI: 10.1136/adc.87.3.207.
Prevention of Pneumococcal Meningitis.
Tan T
Curr Infect Dis Rep. 2002; 4(4):317-323.
PMID: 12126608
DOI: 10.1007/s11908-002-0024-0.
Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.
Lamb H, Ormrod D, Scott L, Figgitt D
Drugs. 2002; 62(7):1041-89.
PMID: 11985490
DOI: 10.2165/00003495-200262070-00005.
Bacterial meningitis: current controversies in approaches to treatment.
Williams A, Nadel S
CNS Drugs. 2001; 15(12):909-19.
PMID: 11735611
DOI: 10.2165/00023210-200115120-00001.
Severe community-acquired meningitis.
BOISSON , ARNAUD , Vialet , Martin
Crit Care. 2000; 3(4):R55-R65.
PMID: 11094483
PMC: 137234.
DOI: 10.1186/cc356.
Impact of antimicrobial agents and chemotherapy from 1972 to 1998.
SWARTZ M
Antimicrob Agents Chemother. 2000; 44(8):2009-16.
PMID: 10898668
PMC: 90006.
DOI: 10.1128/AAC.44.8.2009-2016.2000.
Dexamethasone in bacterial meningitis: to use or not to use?.
Kaul A, Chandwani S
Indian J Pediatr. 1996; 63(5):583-9.
PMID: 10830026
DOI: 10.1007/BF02730800.
Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically....
Fitoussi F, Doit C, Geslin P, Bingen E
Antimicrob Agents Chemother. 1999; 43(10):2372-5.
PMID: 10508009
PMC: 89485.
DOI: 10.1128/AAC.43.10.2372.
Rational prescribing of antibacterials in hospitalised children.
Hoppe J
Pharmacoeconomics. 1996; 10(6):575-93.
PMID: 10164059
DOI: 10.2165/00019053-199610060-00005.
Drug not considered a first-line agent.
Lexchin J
Can Fam Physician. 1998; 44:2376.
PMID: 9839049
PMC: 2277979.
Controlling antibiotic resistance by quelling the epidemic of overuse and misuse of antibiotics.
Conly J
Can Fam Physician. 1998; 44:1769-73, 1780-4.
PMID: 9789653
PMC: 2277853.